Eliciting Dual-Niche Immunological Priming by Acupoint Delivery of Nanovaccines (IMAGE)
Caption
- We report the use of acupoint delivery of nanovaccines (NVs) to elicit a dual-niche immunological priming by simultaneously stimulating mast cell-assisted maturation of CD11b+ dendritic cells (DCs) at the acupoint and directly enriching NVs into the draining lymph nodes (dLNs).
- The dual-niche immunological priming not only provokes antigen presentation by LN-resident CD8α+ DCs, but also induces the accumulation of NVs in B-cell zones, highlights a facile yet versatile platform for advanced nanovaccination toward tumor therapy and infection prevention.
Credit
Lu Wang, Yanhong Sun, Meiling Yan, Lihua Wang, Yiyang Wang, Mengmeng Zhang, Qian Li, Huangan Wu, Jinyao Liu, Chunhai Fan.
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND